Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method

被引:93
|
作者
Smith, RH [1 ]
Jorgensen, WL
Tirado-Rives, J
Lamb, ML
Janssen, PAJ
Michejda, CJ
Smith, MBK
机构
[1] Western Maryland Coll, Dept Chem, Westminster, MD 21157 USA
[2] NCI, ABL, Basic Res Program, Frederick Res & Dev Ctr, Ft Detrick, MD 21702 USA
[3] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[4] CMD, Janssen Res Fdn, B-2350 Vosselaar, Belgium
关键词
D O I
10.1021/jm9804174
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monte Carlo (MC) simulations in combination with a linear response approach were used to estimate the free energies of binding for a series of 12 TIBO nonnucleoside inhibitors of HIV-1 reverse transcriptase. Separate correlations were made for the R-6 and S-6 absolute conformations of the inhibitors, as well as for the analogous N6-monoprotonated species. Models based upon the neutral unbound inhibitors produced overall better fits to experimental values than did those using the protonated unbound inhibitors, with only slight differences between the neutral R-6 and S-6 cases. The best results were obtained with a three-parameter linear response equation containing van der Waals (alpha), electrostatic (beta), and solvent accessible surface area (SASA, gamma) terms. The averaged (R-6 and S-6) rms error was approximately 0.88 kcal/mol for the observed range of 4.06 kcal/mol in inhibitor activities. The averaged values of alpha, beta, and gamma mere -0.150, 0.114, and 0.0286, respectively. Omission of the alpha term gave beta 0.152 and gamma 0.022 with a rms of 0.92. The unweighted van der Waals components were found to be highly attractive but failed to correlate well across the series of inhibitors. Contrastingly, while the electrostatic components are all repulsive, they show a direct correlation with inhibitor activity as measured by Delta G(binding). The role of gamma is primarily to produce an overall negative binding energy, and it can effectively be replaced with a negative constant. During the MC simulations of the unbound solvated inhibitors, the R-6 and S-6 absolute conformations do not interconvert; due to the formation of a favorable hydrogen bond to solvent. In the complex, however, interconversion of these conformations of the inhibitor is observed during the course of the simulations, a phenomenon which is apparently not observed in the crystalline state of the complex. Hydrogen bonding of the inhibitor to the backbone NH of K101 and the lack of such an interaction with the C=O of K101 or with solvent correlate with enhanced activity, as does the ability to assume a number of different orientations of the inhibitor dimethylallyl moiety with respect to residues Y181 and Y188 while retaining contact with W229. Overall, the use of a combination of MC simulation with a linear response method shows promise as a relatively rapid means of estimating inhibitor activities. This approach should be useful in the preliminary evaluation of potential modifications to known inhibitors to enhance activity.
引用
收藏
页码:5272 / 5286
页数:15
相关论文
共 50 条
  • [41] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [42] Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors
    Lai, Ming-Tain
    Tawa, Paul
    Auger, Anick
    Wang, Deping
    Su, Hua-Poo
    Yan, Youwei
    Hazuda, Daria J.
    Miller, Michael D.
    Asante-Appiah, Ernest
    Melnyk, Roman A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 109 - 117
  • [43] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [44] Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse Transcriptase
    Sweeney, Zachary K.
    Harris, Seth F.
    Arora, Nidhi
    Javanbakht, Hassan
    Li, Yu
    Fretland, Jennifer
    Davidson, James P.
    Billedeau, J. Roland
    Gleason, Shelle K.
    Hirschfeld, Donald
    Kennedy-Smith, Joshua J.
    Mirzadegan, Taraneh
    Roetz, Ralf
    Smith, Mark
    Sperry, Sarah
    Suh, Judy M.
    Wu, Jeffrey
    Tsing, Stan
    Villasenor, Armando G.
    Paul, Amber
    So, Guoping
    Heilek, Gabrielle
    Hang, Julie Q.
    Zhou, Amy S.
    Jernelius, Jesper A.
    Zhang, Fang-Jie
    Klumpp, Klaus
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7449 - 7458
  • [45] Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding
    Sluis-Cremer, N
    Temiz, NA
    Bahar, I
    CURRENT HIV RESEARCH, 2004, 2 (04) : 323 - 332
  • [46] Efavirenz Binding Site in HIV-1 Reverse Transcriptase Monomers
    Braz, Valerie A.
    Barkley, Mary D.
    Jockusch, Rebecca A.
    Wintrode, Patrick L.
    BIOCHEMISTRY, 2010, 49 (49) : 10565 - 10573
  • [47] Binding affinity and mechanism of HEPT analogs with HIV-1 reverse transcriptase using the Linear Interaction Energy Approximation
    Tavlarakis, Antonios
    Zhou, Ruhong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 275 - 275
  • [48] Efavirenz Binding to HIV-1 Reverse Transcriptase Monomers and Dimers
    Braz, Valerie A.
    Holladay, Leslie A.
    Barkley, Mary D.
    BIOCHEMISTRY, 2010, 49 (03) : 601 - 610
  • [49] Quantitative structural rearrangement of HIV-1 reverse transcriptase on binding to non-nucleoside inhibitors
    Lawtrakul, L
    Beyer, A
    Hannongbua, S
    Wolschann, P
    MONATSHEFTE FUR CHEMIE, 2004, 135 (08): : 1033 - 1046
  • [50] Quantitative Structural Rearrangement of HIV-1 Reverse Transcriptase on Binding to Non-Nucleoside Inhibitors
    Luckhana Lawtrakul
    Anton Beyer
    Supa Hannongbua
    Peter Wolschann
    Monatshefte für Chemie / Chemical Monthly, 2004, 135 : 1033 - 1046